Cargando…
Covalent CDK7 Inhibitor THZ1 Inhibits Myogenic Differentiation
Covalent CDK7 inhibitor THZ1 is a newly discovered anti-tumor drug.THZ1 affects the function of transcription factor TFIIH by inhibiting CDK7, which in turn affects RNA polymerase II, and ultimately affects transcription initiation. Study found that THZ1 could inhibit proliferation and promote apopt...
Autores principales: | Ma, Xinqi, Kuang, Xielan, Xia, Qing, Huang, Zixin, Fan, Yuting, Ning, Jie, Wen, Jiajie, Zhang, Han, Yan, Jianhua, Zhang, Qingjiong, Shen, Huangxuan, Long, Chongde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134829/ https://www.ncbi.nlm.nih.gov/pubmed/30210638 http://dx.doi.org/10.7150/jca.25395 |
Ejemplares similares
-
Anti-tumor Drug THZ1 Suppresses TGFβ2-mediated EMT in Lens Epithelial Cells via Notch and TGFβ/Smad Signaling Pathway
por: Ning, Jie, et al.
Publicado: (2019) -
PTEN Reduced UVB-Mediated Apoptosis in Retinal Pigment Epithelium Cells
por: He, Jia, et al.
Publicado: (2017) -
Notch signaling pathway mediates Doxorubicin-driven apoptosis in cancers
por: Huang, Zixin, et al.
Publicado: (2018) -
The inhibition of NOTCH2 reduces UVB-induced damage in retinal pigment epithelium cells
por: Liu, Lanying, et al.
Publicado: (2017) -
Curcumin Inhibits Proliferation and Epithelial-Mesenchymal Transition in Lens Epithelial Cells through Multiple Pathways
por: Liu, Huijun, et al.
Publicado: (2020)